Photodynamic therapy for the treatment of choroidal neovascularization secondary to rubella retinopathy

American Journal of Ophthalmology

Volumn 134, Issue 5, 2002, Pages 790-792

  Wang, Leo K ^a   Kansal, Sukesh ^a   Pulido, Jose S ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; VISUAL PIGMENT;

ADULT; ARTICLE; CASE REPORT; CENTRAL SCOTOMA; CONGENITAL RUBELLA SYNDROME; EYE REFRACTION; FIBROSIS; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HEARING IMPAIRMENT; HUMAN; MALE; METAMORPHOSIS; NEOVASCULARIZATION (PATHOLOGY); OPHTHALMOSCOPY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA FOVEA; RETINA HEMORRHAGE; RETINA MACULA LUTEA; RETINOPATHY; RUBELLA; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

EID: 0036847089     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(02)01647-1     Document Type: Article

References (4)

1. Yoser S.L., Forster D.J., Rao N.A. Systemic viral infections and their retinal and choroidal manifestations. Surv Ophthalmol. 37:1993;313-352.
2. Shuler M.F., Borrillo J.L., Ho A.C. Photodynamic therapy update. Curr Opin Ophthalmol. 12:2001;202-206.
3. Sickenberg M., Schmidt-Erfurth U., Miller J.W., et al. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. Arch Ophthalmol. 118:2000;327-336.
4. Verteporfin in Photodynamic Study Group . Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin in Photodynamic Therapy Report 2 . Am J Ophthalmol. 132:2001;659-667.